ALVRX | VIVAX | ALVRX / VIVAX | |
Total Expense Ratio | 1.34 | 0.17 | 788% |
Annual Report Gross Expense Ratio | 1.34 | 0.17 | 788% |
Fund Existence | 22 years | 33 years | - |
Gain YTD | 11.000 | 6.724 | 164% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.07B | 195B | 2% |
Annual Yield % from dividends | 1.17 | 2.06 | 57% |
Returns for 1 year | 6.20 | 9.76 | 64% |
Returns for 3 years | 19.37 | 34.31 | 56% |
Returns for 5 years | 21.98 | 74.87 | 29% |
Returns for 10 years | 39.14 | 116.32 | 34% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ADNIX | 21.14 | 0.26 | +1.25% |
American Beacon ARK Transfmt Innov R5 | |||
CTOGX | 15.36 | 0.19 | +1.25% |
Calamos Timpani SMID Growth R6 | |||
LOGWX | 29.80 | 0.35 | +1.19% |
Lord Abbett Developing Growth F3 | |||
BMGCX | 26.16 | 0.23 | +0.89% |
BlackRock Mid-Cap Growth Equity Inv C | |||
PGIEX | 32.46 | 0.10 | +0.31% |
Putnam Focused Equity C |